Rapid tests for COVID-19 detection (Sars-CoV-2)
Vismederi Pharma, through direct collaboration with leading companies in the sector such as CG Pharma (Korea) and Wizchem (Korea), provides the entire range of rapid antigenic tests:
- Nasal: useful to obtaining the green pass
- Nasopharyngeal: useful to obtaining the green pass
- Salivary: at the moment, without European and Italian validation to obtain the green pass.
The rapid nasal and nasopharyngeal antigen tests for COVID – 19 are validated to obtain the Green Pass
These tests carried out through nasal or nasopharyngeal swabs allow to quickly highlight (10 minutes) the presence of components (antigens) of the virus.
Rapid nasal or nasopharyngeal COVID-19 (SARS-CoV-2) tests must be performed by healthcare professionals or trained personnel who can certify the type, the date it was performed and the result, and transmit the data through the Health Card System to the National Platform-DGC for the issuance of the Certification.